Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
1
pubmed:dateCreated
2011-1-10
pubmed:abstractText
Atherosclerosis is widely accepted as an inflammatory disease involving both innate and adaptive immunity. B cells and/or antibodies have previously been shown to play a protective role against atherosclerosis. Aside from their ability to bind to antigens, antibodies can influence inflammatory responses by interacting with various Fc? receptors on the surface of antigen presenting cells. Although studies in mice have determined that stimulatory Fc? receptors contribute to atherosclerosis, the role of the inhibitory Fc? receptor IIb (Fc?RIIb) has only recently been investigated.
pubmed:grant
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Jan
pubmed:issn
1879-1484
pubmed:author
pubmed:copyrightInfo
Copyright © 2010 Elsevier Ireland Ltd. All rights reserved.
pubmed:issnType
Electronic
pubmed:volume
214
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
73-80
pubmed:meshHeading
pubmed:year
2011
pubmed:articleTitle
The inhibitory Fc?RIIb modulates the inflammatory response and influences atherosclerosis in male apoE(-/-) mice.
pubmed:affiliation
Department of Medicine, Vanderbilt University Medical Center, Nashville, USA. yanice.mendez@vanderbilt.edu
pubmed:publicationType
Journal Article, Research Support, N.I.H., Extramural